Product
Antineoplastic Agents
1 clinical trial
4 indications
Indication
Cardiovascular DiseasesIndication
Heart DiseasesIndication
Vascular DiseasesIndication
CancerClinical trial
Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)Status: Not yet recruiting, Estimated PCD: 2024-06-30